QQ客服 官方微博 反馈留言

	Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy
	Li, Kui; Tian, Hongqi
	2019
卷号	27期号:3页码:244-256
关键词	Small-molecule inhibitors PD-1 PD-L1 immune checkpoint targeted therapy tumour immunotherapy clinical and preclinical research
ISSN号	1061-186X
DOI	10.1080/1061186X.2018.1440400
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6346385
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Li, Kui,Tian, Hongqi. Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy[J],2019,27(3):244-256.
APA	Li, Kui,&Tian, Hongqi.(2019).Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy.,27(3),244-256.
MLA	Li, Kui,et al."Development of small-molecule immune checkpoint inhibitors of PD-1/PD-L1 as a new therapeutic strategy for tumour immunotherapy".27.3(2019):244-256.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。